Skip to main content

What the FDA labels say about taking them together

Acetaminophen and ublituximab

Ublituximab's FDA label of February 19, 2026 names acetaminophen in its warnings and precautions section; the acetaminophen labels PlainMeds reads (4) do not name ublituximab. The ublituximab label: “In Studies 1 and 2, patients received methylprednisolone (or an equivalent steroid), an antihistamine, and possibly other pre-medication (i.e., acetaminophen) to reduce the risk of infusion reactions prior to each …”

Check it at the source: the acetaminophen FDA label on DailyMed (effective November 13, 2024, Kenvue Brands LLC); the ublituximab FDA label on DailyMed (effective February 19, 2026).

What does the acetaminophen label say about ublituximab?

Acetaminophen's label (effective November 13, 2024) and its 3 other brand-application labels do not name ublituximab in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Tylenol 8 HR Arthritis Pain), Kenvue Brands LLC, effective November 13, 2024 (SPL set 3af22fc8-e4e0-4863-8696-6bc1257047cb), via openFDA; the full label on DailyMed

What does the ublituximab label say about acetaminophen?

Ublituximab label, warnings and precautions

In Studies 1 and 2 [see Clinical Studies (14) ], patients received methylprednisolone (or an equivalent steroid), an antihistamine, and possibly other pre-medication (i.e., acetaminophen) to reduce the risk of infusion reactions prior to each infusion.

Source: FDA drug label (BRIUMVI), TG Therapeutics, Inc., effective February 19, 2026 (SPL set 3a77cd8c-811b-407c-9140-d0c5c26435c2), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

89Acetaminophen generic labelers
0Ublituximab generic labelers
AcetaminophenUblituximab
Labeled forFever, Cough and cold, PainMultiple sclerosis
Boxed warningYesNo
Pharmacy cost (NADAC)$0.0339 per unit 500 mg capletn/a
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?